Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi ...Middle East

PR Newswire - News
Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi
MILWAUKEE, May 10, 2023 /PRNewswire/ -- Ademi LLP is investigating CTI BioPharma (Nasdaq: CTIC) for possible breaches of fiduciary duty and other violations of law in its transaction with Sobi. Click here to learn how to join the action https://www.ademilaw.com/case/cti-biopharma-corp or...

Hence then, the article about shareholder alert ademi llp investigates whether cti biopharma corp has obtained a fair price in its transaction with sobi was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi )

Apple Storegoogle play

Last updated :

Also on site :